Alterity Therapeutics (ATHE) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

ATHE Alterity Therapeutics

Watchlist

1.0700
0.00000.00%

Close Nov 22 16:00 ET

1.0700
0.00000.00%

Post 19:49 ET

9.35MMarket Cap-526P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Alterity Therapeutics Alerts Investors on Potential Risks
TipRanksNov 21 17:37 ET
Alterity Therapeutics Advances in Neurodegenerative Drug Trials
TipRanksNov 21 17:37 ET
Alterity Therapeutics Appoints New Company Secretary
TipRanksNov 18 23:19 ET
Alterity Therapeutics Unveils New Advances for MSA Tracking
TipRanksNov 11 19:28 ET
Alterity Therapeutics Prepares for 2024 Annual General Meeting
TipRanksOct 22 20:57 ET
Alterity Therapeutics to Participate in a Fireside Chat at the 2024 Maxim Healthcare Virtual Summit on 17 October 2024
GlobeNewswireOct 14 07:35 ET

Comments

Teddy123

Oct 11 06:54

Alterity Therapeutics Announces Presentation of New Data Describing Neuroprotection of ATH434 at Neuroscience Meeting

$Alterity Therapeutics (ATHE.US)$
11/10/2024 - 19:35
MELBOURNE, Australia and SAN FRANCISCO, Oct. 11, 2024 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today announced promising new data related to ATH434 were presented a...